Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration

por Wangpaichitr, Medhi, Theodoropoulos, George, Nguyen, Dan J. M., Wu, Chunjing, Spector, Sydney A., Feun, Lynn G., Savaraj, Niramol
Publicado 2021

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer

por Wangpaichitr, Medhi, Wu, Chunjing, Li, Ying Ying, Nguyen, Dan J.M., Kandemir, Hande, Shah, Sumedh, Chen, Shumei, Feun, Lynn G., Prince, Jeffrey S., Kuo, Macus T., Savaraj, Niramol
Publicado 2017

Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer

por Wu, Chunjing, Spector, Sydney A., Theodoropoulos, George, Nguyen, Dan J. M., Kim, Emily Y., Garcia, Ashley, Savaraj, Niramol, Lim, Diane C., Paul, Ankita, Feun, Lynn G., Bickerdike, Michael, Wangpaichitr, Medhi
Publicado 2023